Stem Cell Panel Expects to Award Grants
By Associated Press,
Associated Press [cites CGS]
| 01. 07. 2005
Stem Cell Panel Expects to Award Grants
"We have a responsibility to move as quickly as possible," Robert Klein said Thursday. "I admit that I am an optimist."
The institute was created by California voters in November when they approved a $3 billion bond to fund stem cell research over the next decade.
The 29-member committee appointed to manage the institute met Thursday and began to rectify the mind-numbing bureaucratic problems that need to be solved before the agency can be launched in full.
The Independent Citizen's Oversight Committee sorted through issues ranging from mundane personnel matters to grappling with the appropriateness of patenting genes and other life forms. Its only business in one earlier meeting was to appoint Klein as chairman and biotech company founder Edward Penhoet as vice chairman.
The committee members began the process of getting a $3 million loan from the state treasurer so the agency can hire staff and begin operating. They also appointed a seven-member committee to locate a headquarters and find office space.
Many of the board members, who were appointed by Gov...
Related Articles
By Katherine Long, Ben Foldy, and Lingling Wei, The Wall Street Journal | 12.13.2025
Inside a closed Los Angeles courtroom, something wasn’t right.
Clerks working for family court Judge Amy Pellman were reviewing routine surrogacy petitions when they spotted an unusual pattern: the same name, again and again.
A Chinese billionaire was seeking parental...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Sarah Kliff, The New York Times | 12.10.2025
Micah Nerio had known since his early 30s that he wanted to be a father, even if he did not have a partner. He spent a decade saving up to pursue surrogacy, an expensive process where he would create embryos...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
